Levofloxacin
- Product NDC
- 61919-741
- 11-digit product format
- 619190741
- Labeler code
- 61919
- Product ID
- 61919-741_b89d05de-feee-4ce7-8edd-4dd1bdf8ee9e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levofloxacin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct Rx
- Application
- ANDA200839
- Marketing category
- ANDA
- Marketing start
- 2015-01-01
- Marketing end
- 0000-00-00
- Substance
- LEVOFLOXACIN
- Active strength
- 750 mg/1
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| addb5519-f7ae-4d4e-b9ca-f782a1597fd3 | Product name | 2 | 20210610 |
| fb758c6a-fdee-40a8-99c2-46f79c3ff90c | Product name | 4 | 20200807 |
| 1a81e9a9-11c3-4fcf-b5dd-f6798fef8e6d | Product name | 1 | 20190618 |
| aea4a616-4dfe-45f6-94bb-8b9063056ceb | Product name | 6 | 20190611 |
| 2246ce8e-a477-4dc3-b6d6-fe9973c18ed1 | Product name | 1 | 20180821 |
| 5a6c788d-375b-4565-a8ae-67c179a30c93 | Product name | 1 | 20180212 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61919-741-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0393-f424-e053-dadaa90a57ce | Levofloxacin |
| 61919-741-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0393-f424-e053-dadaa90a57ce | Levofloxacin |
| 61919-741-14 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0393-f424-e053-dadaa90a57ce | Levofloxacin |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61919-741-05 | Levofloxacin | 5 in 1 BOTTLE | TABLET | 5 | 2 | |
| 61919-741-10 | Levofloxacin | 10 in 1 BOTTLE | TABLET | 10 | 2 | |
| 61919-741-14 | Levofloxacin | 14 in 1 BOTTLE | TABLET | 14 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 61919-741-05 | EA - Each | 61919-741 | 47f8688b-d1d3-47f7-be3e-afe38dd82445 | 1 | 2016-09-02 |
| 61919-741-10 | EA - Each | 61919-741 | 2d826b01-e2c8-4cc9-9300-f862b4639740 | 1 | 2016-09-02 |
| 61919-741-14 | EA - Each | 61919-741 | 2957a4ed-95af-4a57-8a79-69a5dc201349 | 1 | 2016-09-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LEVOFLOXACIN | ACTIVE INGREDIENT | 6GNT3Y5LMF | LEVOFLOXACIN TABLET [DIRECT RX] | 2 | |
| LEVOFLOXACIN ANHYDROUS | ACTIVE MOIETY | RIX4E89Y14 | LEVOFLOXACIN TABLET [DIRECT RX] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | LEVOFLOXACIN TABLET [DIRECT RX] | 2 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | LEVOFLOXACIN TABLET [DIRECT RX] | 2 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | LEVOFLOXACIN TABLET [DIRECT RX] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LEVOFLOXACIN TABLET [DIRECT RX] | 2 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | LEVOFLOXACIN TABLET [DIRECT RX] | 2 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | LEVOFLOXACIN TABLET [DIRECT RX] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LEVOFLOXACIN TABLET [DIRECT RX] | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 311296 | levoFLOXacin 750 MG Oral Tablet | PSN | 593f7324-6cc4-4259-b4e5-6952be31a7bd | 2 |
| 311296 | levofloxacin 750 MG Oral Tablet | SCD | 593f7324-6cc4-4259-b4e5-6952be31a7bd | 2 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 61919-741-05 | 61919074105 | 5 in 1 BOTTLE | Historical |
| 61919-741-10 | 61919074110 | 10 in 1 BOTTLE | Historical |
| 61919-741-14 | 61919074114 | 14 in 1 BOTTLE | Historical |